Kinetic analysis of hepatobiliary transport of drugs: Importance of carrier-mediated transport

被引:4
|
作者
Yamazaki, M
Nishigaki, R
Suzuki, H
Sugiyama, Y
机构
[1] UNIV TOKYO, FAC PHARMACEUT SCI, BUNKYO KU, TOKYO 113, JAPAN
[2] TOHO UNIV, SCH PHARMACEUT SCI, DEPT PHARMACOKINET & BIOPHARMACEUT, FUNABASHI, CHIBA 274, JAPAN
关键词
organic anion; bile acid; primary active transport; multispecific anion transporter; Eisai hyperbilirubinemic rat;
D O I
10.1248/yakushi1947.115.12_953
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The liver is the major organ involved in the metabolism and elimination of xenobiotics. Evaluating accurately hepatic clearance is very important for predicting the pharmacological effect and/or side-effects of drugs, as well as changes in drug disposition during disease. Recently, for many endogenous and exogenous compounds (including drugs), it has been reported that carrier-mediated transport contributes to hepatic uptake and/or biliary excretion. In particular, primary active transport mechanisms have been shown to be responsible for the biliary excretion of anticancer drugs, endogenous bile acids and organic anions including glutathione and glucuronic acid conjugates. We have found that a rate-limiting step for several drugs in terms of the hepatic clearance was the membrane transport process. For these drugs, such a saturable transport process can be one of the major determinants which influence not only hepatic clearance itself but also disposition (in other words, plasma elimination) in the whole body. We reviewed the carrier-mediated transport mechanisms involved in the hepatic uptake and biliary excretion processes, the multiplicity of transport systems, and further, the physiological meaning of these complex transport systems in the body.
引用
收藏
页码:953 / 977
页数:25
相关论文
共 50 条
  • [1] Carrier-mediated intestinal transport of drugs
    Tsuji, A
    Tamai, I
    PHARMACEUTICAL RESEARCH, 1996, 13 (07) : 963 - 977
  • [2] CARRIER-MEDIATED TRANSPORT IN THE HANDLING OF DRUGS BY THE LIVER
    MEIJER, DKF
    NEEF, C
    GROOTHUIS, GMM
    PHARMACY INTERNATIONAL, 1983, 4 (07): : 184 - 184
  • [3] CARRIER-MEDIATED TRANSPORT IN THE RENAL HANDLING OF DRUGS
    VANGINNEKEN, CAM
    PHARMACY INTERNATIONAL, 1983, 4 (07): : 183 - 183
  • [4] CARRIER-MEDIATED HEAT TRANSPORT
    GODDARD, JD
    SCHULTZ, JS
    SUCHDEO, SR
    CHEMICAL ENGINEERING SCIENCE, 1974, 29 (10) : 2041 - 2047
  • [5] CARRIER-MEDIATED AUXIN TRANSPORT
    RUBERY, PH
    SHELDRAKE, AR
    PLANTA, 1974, 118 (02) : 101 - 121
  • [6] ORGANOTROPISM BY CARRIER-MEDIATED TRANSPORT
    FRIMMER, M
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (10) : 395 - 397
  • [7] CARRIER-MEDIATED ION TRANSPORT
    LAUGER, P
    SCIENCE, 1972, 178 (4056) : 24 - &
  • [8] Carrier-mediated transport of monocarboxylate drugs in the pigmented rabbit conjunctiva
    Horibe, Y
    Hosoya, K
    Kim, KJ
    Lee, VHL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1998, 39 (08) : 1436 - 1443
  • [9] KINETIC CRITERIA FOR CARRIER-MEDIATED TRANSPORT MECHANISMS IN MEMBRANE-VESICLES
    HOPFER, U
    FEDERATION PROCEEDINGS, 1981, 40 (10) : 2480 - 2485
  • [10] Study on the visualization of carrier-mediated transport
    Okada, Masahiro
    Yamaguchi, Hiroaki
    Kobayashi, Minako
    Takeuchi, Toshiko
    Tanemoto, Masayuki
    Unno, Michiaki
    Abe, Takaaki
    Hishinuma, Takanori
    Goto, Junichi
    Mano, Nariyasu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 181 - 182